Vertex Pharmaceuticals Incorporated (FRA:VX1)
Germany · Delayed Price · Currency is EUR 330.45
-2.25 (-0.68%)
At close: Sep 30, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 771.50M | Log In | Log In | Log In | Log In | Upgrade |
Kalydeco | - | Log In | Log In | Log In | Log In | Upgrade |
Kalydeco Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Orkambi | - | Log In | Log In | Log In | Log In | Upgrade |
Orkambi Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Symdeko / Symkevi | - | Log In | Log In | Log In | Log In | Upgrade |
Symdeko / Symkevi Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Trikafta / Kaftrio | 10.24B | Log In | Log In | Log In | Log In | Upgrade |
Trikafta / Kaftrio Growth | 8.93% | Log In | Log In | Log In | Log In | Upgrade |
Casgevy | 10.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other Collaborative and Royalty | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty | - | Log In | Log In | Log In | Log In | Upgrade |
Other Collaborative and Royalty Growth | - | Log In | Log In | Log In | Log In | Upgrade |
United States Product | 6.68B | Log In | Log In | Log In | Log In | Upgrade |
United States Product Growth | 12.27% | Log In | Log In | Log In | Log In | Upgrade |
Outside of United States Product | 4.34B | Log In | Log In | Log In | Log In | Upgrade |
Outside of United States Product Growth | 6.92% | Log In | Log In | Log In | Log In | Upgrade |